(INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION
ABOUT AROTECH, THE PROPOSED MERGER TRANSACTION AND RELATED MATTERS. The proposed merger transaction will be submitted to Arotechs stockholders for their consideration. Investors and security holders will be able to obtain free copies of the
Proxy Statement (when available) and other documents filed by Arotech with the SEC through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed by Arotech with the SEC will also be available free of charge on
Arotechs website at www.arotech.com or by contacting Arotechs Investor Relations contact at Scott.Schmidt@arotechusa.com.
Participants in the Solicitation
Arotech and its
directors and certain of its executive officers and employees may be deemed to be participants in the solicitation of proxies from Arotechs stockholders with respect to the proposed merger transaction under the rules of the SEC. Information
about the directors and executive officers of Arotech and their ownership of shares of Arotechs common stock is set forth in its Annual Report on Form 10-K for the year ended December 31, 2018,
which was filed with the SEC on March 7, 2019, its proxy statement for its 2019 annual meeting of stockholders, which was filed with the SEC on March 22, 2019 and in subsequent documents filed with the SEC, including the Proxy Statement.
Additional information regarding the persons who may be deemed participants in the proxy solicitations and a description of their direct and indirect interests in the merger transaction, by security holdings or otherwise, will also be included in
the Proxy Statement and other relevant materials to be filed with the SEC when they become available. You may obtain free copies of this document as described above.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Arotech
generally identifies forward-looking statements by terminology such as may, will, should, expects, plans, anticipates, could, intends,
target, projects, contemplates, believes, estimates, predicts, potential or continue or the negative of these terms or other similar words. These
statements are only predictions. Arotech has based these forward-looking statements largely on its then-current expectations and projections about future events and financial trends as well as the beliefs and assumptions of management.
Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Arotechs control. Arotechs actual results could differ materially from those stated or implied
in forward-looking statements due to a number of factors, including but not limited to: (i) risks associated with Arotechs ability to obtain the stockholder approval required to consummate the proposed merger transaction and the timing of
the closing of the proposed merger transaction, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of the proposed merger transaction will not occur; (ii) the
outcome of any legal proceedings that may be instituted against the parties and others related to the merger agreement; (iii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the
merger agreement, (iv) unanticipated difficulties or expenditures relating to the proposed merger transaction, the response of business partners and competitors to the announcement of the proposed merger transaction, and/or potential
difficulties in employee retention as a result of the announcement and pendency of the proposed merger transaction; and (v) those risks detailed in Arotechs most recent Annual Report on Form 10-K and subsequent reports filed
with the SEC, as well as other documents that may be filed by Arotech from time to time with the SEC. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Arotech cannot assure you that the events and
circumstances reflected in the forward-looking statements will be achieved or occur, and actual results could differ materially from
2